Financials • Life Insurance
$116.87 ▲ +1.50
(+1.30%)
MKT CAP: $40.32B • VOL: 1.36M
52W L $92 52W H $128
PRU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $60.77B | $70.41B | $53.98B |
| YoY Revenue Growth % | -13.7% | +30.4% | — |
| Gross Profit | $26.74B | $30.98B | $23.75B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.22B | $3.22B | $2.94B |
| Operating Margin % | 6.9% | 4.6% | 5.4% |
| Net Income (GAAP) | $3.58B | $2.73B | $2.49B |
| EBITDA (Normalized) | $6.41B | $5.75B | $4.88B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.27B | $8.50B | $6.51B |
| Capital Expenditures (CapEx) | $2.73B | $3.17B | $2.43B |
| Free Cash Flow (FCF) | $3.54B | $5.33B | $4.08B |
| FCF Margin % | 5.8% | 7.6% | 7.6% |
| Return on Invested Capital (ROIC %) | 10.6% | 8.9% | 5.9% |
| Cash & Short-Term Equivalents | $19.71B | $18.50B | $7.13B |
| Total Debt (Short + Long Term) | $18.86B | $19.19B | $15.16B |
| Total Stockholders' Equity | $32.44B | $27.87B | $31.09B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PRU.